Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Guofang Yin, Hua Xiao, Yi Liao, Chengliang Huang & Xianming Fan. (2020) Construction of a Nomogram After Using Propensity Score Matching to Reveal the Prognostic Benefit of Tumor Resection of Stage IV M1a Nonsmall Cell Lung Cancer Patients. Cancer Investigation 38:5, pages 277-288.
Read now
Read now
Jianqing Deng, Zhipeng Ren, Jiaxin Wen, Bo Wang, Xiaobin Hou, Zhiqiang Xue & Xiangyang Chu. (2018) Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer. Cancer Management and Research 10, pages 6143-6156.
Read now
Read now
Articles from other publishers (19)
Yuexin Tong, Liming Jiang, Yan Gong, Dejing Zhu & Dongxu Zhao. (2023) Worth it or not? Analysis of survival benefit from primary tumor resection and individualized prediction of overall survival for lung cancer patients with bone metastasis. Asian Journal of Surgery.
Crossref
Crossref
Cheng-Mao Zhou, Ying Wang, Qiong Xue & Yu Zhu. (2023) Differentiation of Bone Metastasis in Elderly Patients With Lung Adenocarcinoma Using Multiple Machine Learning Algorithms. Cancer Control 30.
Crossref
Crossref
Ziran Zhao, Yibo Gao, Fengwei Tan, Qi Xue, Shugeng Gao & Jie He. (2023) Specific organ metastases and prognosis in lung adenocarcinoma. Thoracic Cancer 14:8, pages 736-745.
Crossref
Crossref
Xilin Zhang, Qiuqiang Chen, Ying He, Qian Shi, Chengyi Yin, Yanping Xie, Huanming Yu, Ying Bao, Xiang Wang, Chengwu Tang & Zhaohui Dong. (2023) STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Crossref
Jiaying Yuan, Zhiyuan Cheng, Jian Feng, Chang Xu, Yi Wang, Zixiu Zou, Qiang Li, Shicheng Guo, Li Jin, Gengxi Jiang, Yan Shang & Junjie Wu. (2022) Prognosis of lung cancer with simple brain metastasis patients and establishment of survival prediction models: a study based on real events. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Xiaowei Tie, Lianlian Chen, Xiaomin Li, Wenjuan Zha & Yangchen Liu. (2022) A nomogram model of postoperative prognosis for metastatic lung adenocarcinoma: A study based on the SEER database. Medicine 101:41, pages e31083.
Crossref
Crossref
Ruhan Zhao, Yunnan Dai, Xinyang Li & Cuimin Zhu. (2022) Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis. Scientific Reports 12:1.
Crossref
Crossref
Marcus Unterrainer, Julian Taugner, Lukas Käsmann, Amanda Tufman, Niels Reinmuth, Minglun Li, Lena M. Mittlmeier, Peter Bartenstein, Wolfgang G. Kunz, Jens Ricke, Claus Belka, Chukwuka Eze & Farkhad Manapov. (2021) Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition. European Journal of Nuclear Medicine and Molecular Imaging 49:4, pages 1407-1416.
Crossref
Crossref
Hongchao Chen, Chen Huang, Huiqing Ge, Qianshun Chen, Jing Chen, Yuqiang Li, Haiyong Chen, Shiyin Luo, Lilan Zhao & Xunyu Xu. (2022)
A novel
LASSO
‐derived prognostic model predicting survival for non‐small cell lung cancer patients with M1a diseases
. Cancer Medicine 11:6, pages 1561-1572.
Crossref
Crossref
P.J.M. Joosten, A.J. de Langen, V. van der Noort, K. Monkhorst, H.M. Klomp, A.A.F.A. Veenhof, C. Dickhoff, E.F. Smit & K.J. Hartemink. (2021) The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer. Lung Cancer 161, pages 141-151.
Crossref
Crossref
Isabelle Opitz. (2021) Commentary: Surgery expanding to stage IV non–small cell lung cancer treatment?!. The Journal of Thoracic and Cardiovascular Surgery 161:4, pages 1508-1509.
Crossref
Crossref
Lukas Käsmann, Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Maurice Dantes, Nina-Sophie Schmidt-Hegemann, Sanziana Schiopu, Claus Belka & Farkhad Manapov. (2020) Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy. Radiation Oncology 15:1.
Crossref
Crossref
Kathrin Gennen, Lukas Käsmann, Julian Taugner, Chukwuka Eze, Monika Karin, Olarn Roengvoraphoj, Jens Neumann, Amanda Tufman, Michael Orth, Simone Reu, Claus Belka & Farkhad Manapov. (2020) Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy. Radiation Oncology 15:1.
Crossref
Crossref
Matthias Guckenberger, Kuno Lehmann & Isabelle Opitz. (2020) Oligometastasiertes nichtkleinzelliges Lungenkarzinom: lokaltherapeutische Optionen zur Behandlung von Lungen- und NebennierenmetastasenOligometastatic non-small-cell lung cancer: local treatment options for pulmonary and adrenal metastases. Der Onkologe 26:9, pages 800-815.
Crossref
Crossref
Lukas Käsmann, Reem Abdo, Chukwuka Eze, Maurice Dantes, Julian Taugner, Kathrin Gennen, Olarn Roengvoraphoj, Dirk Rades, Claus Belka & Farkhad Manapov. (2020) External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy. Lung 198:1, pages 201-206.
Crossref
Crossref
Zhangheng Huang, Chuan Hu, Yuexin Tong, Zhiyi Fan & Chengliang Zhao. (2020) Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases. Medicine 99:31, pages e21339.
Crossref
Crossref
Emily Stone & Shalini K. Vinod. (2019) Oligometastatic Disease in NSCLC — Not Just Wishful Thinking?. Journal of Thoracic Oncology 14:12, pages 2042-2045.
Crossref
Crossref
Huaping Tang, Xianzhang Han, Meng Li, Tingtian Li & Yueqin Hao. (2019) Linc00221 modulates cisplatin resistance in non-small-cell lung cancer via sponging miR-519a. Biochimie 162, pages 134-143.
Crossref
Crossref
Yi Liao, Xianming Fan & Xue Wang. (2019) Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage�IV non‑small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis. Oncology Letters.
Crossref
Crossref